<DOC>
	<DOCNO>NCT00549497</DOCNO>
	<brief_summary>GW870086X novel inhale steroid improve safety profile steroid also less potent . This study look high dos confirm improve safety profile .</brief_summary>
	<brief_title>A Randomized Study Evaluating Steroid Hormone Levels , Safety And Tolerability Of GW870086X In Healthy Volunteers</brief_title>
	<detailed_description>A randomized , double-blind , placebo-controlled , dose ascending , 3-cohort parallel group study measure systemic cortisol profile evaluate safety , tolerability pharmacokinetics GW870086X , administer single dos ( 12mg 15mg ) , repeat dos 3 day ( 6mg , 12mg 15mg ) healthy male subject .</detailed_description>
	<criteria>Inclusion criterion : Healthy male subject Liver function test normal 18 45 year old Non smoker Can provide write informed consent Available complete whole trial Can use inhalation device correctly Able read , understand write English Exclusion criterion : Deemed suitable healthy subject History sensitivity study medication Any history breathing problem adult life Participated another trial within 30 day 5 halflives new chemical entity Exposed 4 new chemical entity within 12 month Donated &gt; 500 mL blood within 2 month screen Haemoglobin level &lt; 13g/dl Use prescription nonprescription drug within 7 day first dose Taking drug significantly inhibit cytochrome P450 subfamily enzyme CYP3A4 Drinks 4 unit day 28 unit week Can use DISKHALER device correctly Positive HepB , HepC within 3 month screen Positive HIV test Positive pre study drug/alcohol screen Significant cardiac conduction abnormality Risk noncompliance</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>GW870086X , inhale , asthma , cortisol , pharmacokinetics , osteocalcin</keyword>
</DOC>